Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00485862 · ClinicalTrials.gov registry record · Phase 4
Combination Therapy in Patients With Depression
A Phase 4 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 4
- Development phase
- 214
- Enrollment target
NCT00485862 is a Phase 4 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 214 participants.
The verdict
NCT00485862, a Phase 4 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 214 participants
- Enrollment target
Study Summary
The purpose of the study is to compare sertraline and atomoxetine/sertraline combination therapy in patients with persistent depressive symptoms.
Interventions
- DRUG Placebo
- DRUG Sertraline
- DRUG Atomoxetine Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2003-06 |
| Est. Completion | 2005-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00485862
The ClinicalTrials.gov registry entry for NCT00485862 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 214 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00485862 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00485862 about?
NCT00485862 is a clinical study titled "Combination Therapy in Patients With Depression". The purpose of the study is to compare sertraline and atomoxetine/sertraline combination therapy in patients with persistent depressive symptoms.
What is the current status of trial NCT00485862?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 214 participants. The study started on 2003-06. Estimated completion is 2005-01.
What interventions are being tested in trial NCT00485862?
The interventions under investigation include: Placebo (DRUG), Sertraline (DRUG), Atomoxetine Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00485862?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.